Investing analyses

PAY Paymentus
Sectorpayments
Mkt cap$3.1B
Allocation3.9%
Statuswatchlist
Atlas3.5/5

atlasAdd

2026-04-03 · earnings-review · Q4 FY25 confirmed the pattern: beat on all metrics, guidance for next year looks conservative, margins at record highs, but the beat magnitude is compressing · Conviction 3.5/5

Open analysis → · PDF unavailable

Preview
# PAY — Q4 FY25 Earnings Review (Atlas)

> Date: 2026-04-03
> Quarter: Q4 FY25 (ended Dec 31, 2025)
> Market cap: $3.1B | EV/TTM Rev: 2.3x | Revenue growth: 28.2% YoY (Q4), 37.3% FY2025

## Verdict

Q4 FY25 confirmed the pattern: beat on all metrics, guidance for next year looks conservative, margins at record highs, but the beat magnitude is compressing. Revenue of $330.5M beat the $309.5M guide midpoint by 6.8% — the narrowest beat in 7 tracked quarters, and the first time revenue landed at the low end of its own guide range. The operating leverage story is excellent (adj EBITDA margin 37.3%, FCF $125M for FY25), but the growth deceleration from 56.5% to 28.2% over 5 quarters is now squarely visible in the headline number. The FY26 guide of $1.4B (+17%) is almost certainly conservative based on the documented 13-19% initial FY guide beat pattern, but the question is whether the beat narrows further. **Conviction: 3.5/5** — holding at the same level as my stock analysis from April 2. Q1 FY26 (~May 2026) is the decisive data point.

## Qualification Gate

| Criterion | Threshold | Actual | Pass/Fail |
|-----------|-----------|--------|-----------|
| Revenue YoY growth | >30% | 28.2% (Q4), 37.3% (FY25) | **Borderline** — Q4 below 30%, FY above |
| Gross margin | >60% | 25.4% GAAP | **FAIL** — payments model; contribution margin 32.3% is the operative metric |
| Revenue per quarter | >$50M | $330.5M | **Pass** |
| Data availability | 4+ quarters | 16 quarters | **Pass** |
| Share dilution | <10% annual | ~0.5%/yr (129.1M to 129.4M) | **Pass** |
| GAAP profitability trajectory | Improving/positive | Op margin 7.3% (record); NI positive 10 consecutive Q | **Pass** |

**Gate note:** GAAP gross margin fails because PAY is a consumption-based payment processor, not SaaS. GAAP COGS includes interchange/network pass-through fees PAY does not control. Contribution profit (gross profit + other cost of revenue) is the correct profitability metric, analogous to how HOOD, SOFI, a

*…truncated*

wsmStrong

2026-04-08 · stock-analysis · FY24 was the anomalous year — the hyper-growth year when large enterprise billers went live and supercharged the QoQ numbers

Open analysis → · PDF unavailable

Preview
# PAY — Paymentus Stock Analysis

**Date:** 2026-04-06
**Author:** wsm
**Stock Price:** $24.84 | **Market Cap:** $3.12B | **EV:** $2.80B
**Position:** None (Watchlist)

---

## Thesis

**PAY is the best-run company I'm not buying.** Founder-led, zero debt, $321M cash, 37% EBITDA margins on contribution profit, 61% incremental margins, SBC at 1.7% of revenue — this is textbook operational excellence. But the growth engine is structurally decelerating, and the revenue/transaction gap convergence pattern tells me the market is pricing this correctly at 2.1x run-rate P/S. The question isn't whether PAY is a good business — it plainly is. The question is whether the growth trajectory justifies a position in a concentrated portfolio. At +17% guided and +16% transaction growth as the structural floor, I don't see the asymmetry I need.

---

## 1. Revenue Trajectory — The Central Question

### QoQ Grid (Years Across, Quarters Down)

| Quarter | FY22 QoQ | FY23 QoQ | FY24 QoQ | FY25 QoQ | Trend |
|---------|----------|----------|----------|----------|-------|
| Q1 | +8.0% | +12.2% | +12.2% | +6.7% | **Decelerating** |
| Q2 | +2.8% | +0.4% | +6.8% | +1.8% | Seasonal trough (normal) |
| Q3 | +6.8% | +2.4% | +17.3% | +10.9% | **Decelerating** from FY24 peak |
| Q4 | +3.1% | +8.1% | +11.4% | +6.4% | **Decelerating** |

**Verdict:** FY24 was the anomalous year — the hyper-growth year when large enterprise billers went live and supercharged the QoQ numbers. FY25 QoQ across every single quarter is lower than FY24. FY25 is normalising back toward FY22-FY23 cadence. **This is not a one-quarter blip — it's a structural reversion.**

### YoY Grid

| Quarter | FY23 YoY | FY24 YoY | FY25 YoY |
|---------|----------|----------|----------|
| Q1 | +27.1% | +24.7% | **+48.8%** |
| Q2 | +24.1% | +32.6% | **+41.9%** |
| Q3 | +18.9% | +52.0% | **+34.2%** |
| Q4 | +24.7% | +56.5% | **+28.2%** |

FY25 YoY decelerated every quarter: 48.8% → 41.9% → 34.2% → 28.2%. Five consecutive quarters of YoY d

*…truncated*
Rolling earnings (raw)
# PAY — Rolling Earnings Summary

> Last updated: 2026-04-03
> Covers: Q1 FY25 – Q4 FY25 (4-quarter window)

## Performance Grid

| | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
| | Mar-25 | Jun-25 | Sep-25 | Dec-25 |
|---|---|---|---|---|
| Revenue ($m) | 275.2 | 280.1 | 310.7 | 330.5 |
| YoY % | +48.8% | +41.9% | +34.2% | +28.2% |
| QoQ % | +6.7% | +1.8% | +10.9% | +6.4% |
| Contribution Profit ($m) | 87.6 | 93.5 | 98.3 | 106.9 |
| Adj EBITDA Margin % | 34.2% | 33.9% | 36.5% | 37.3% |
| GAAP Op Margin % | 5.7% | 5.7% | 6.4% | 7.3% |
| Net Income ($m) | 13.8 | 14.7 | 17.7 | 20.7 |
| EPS (Non-GAAP) | $0.14 | $0.15 | $0.17 | $0.20 |
| FCF ($m) | 41.1 | 22.5 | 25.7 | 35.7 |
| Transactions (M) | 173.2 | 175.8 | 182.3 | 192.7 |
| Rev/Transaction ($) | $1.59 | $1.59 | $1.70 | $1.72 |
| Verdict | Strong beat | In-range | Solid beat | Low-end |

**Trajectory:** Revenue growth decelerating from 48.8% (Q1) to 28.2% (Q4) across FY2025. Margins expanding throughout — adj EBITDA margin hit record 37.3% in Q4. FCF inflected from $27M (FY24) to $125M (FY25). Management guided FY26 at $1.39-1.41B (+17% YoY), but historical pattern suggests significant conservatism.

## Promise Tracker

| Quarter | Promise | Status | Notes |
|---------|---------|--------|-------|
| Q4 FY24 | FY25 Rev $1,040-1,060M | **Crushed** | Actual $1,196.5M (+13.1% above top) |
| Q4 FY24 | FY25 EBITDA $112-116M | **Crushed** | Actual $137.4M (+18.4% above top) |
| Q1 FY25 | Q2 Rev $255-260M | **Crushed** | Actual $280.1M (+8.8% vs mid) |
| Q1 FY25 | FY25 raise to $1,075-1,090M | **Crushed** | Final actual $1,196.5M |
| Q2 FY25 | Q3 Rev $278-282M | **Crushed** | Actual $310.7M (+11.0% vs mid) |
| Q3 FY25 | Q4 Rev $307-312M | **Beat** | Actual $330.5M (+6.8% vs mid) — narrowest beat in 7Q (revised from Met by atlas) |
| Q4 FY25 | FY26 Rev $1,390-1,410M | **Pending** | CEO: "achievable without new clients" |
| Q4 FY25 | FY26 EBITDA $157-167M | **Pending** | |
| Q4 FY25 | "Could more than double in existing base" | **Watch** | Structural claim; no timeline |

## Language Shift Monitor

| Quarter | Growth Tone | Margin Tone | Competitive Tone |
|---------|------------|-------------|------------------|
| Q1 FY25 | Very bullish — strongest sequential add in history | Not available (no transcript) | Not available |
| Q2 FY25 | Muted — seasonal Q2 softness | Not available | Not available |
| Q3 FY25 | Resurgent — re-acceleration after Q2 | Positive — expanded 260bps QoQ | Not available |
| Q4 FY25 | Peak confidence — "quadrupled in 5 years", "massive pipeline" x2 | Very positive — 37.3% record margin | Dismissive — "strong positioning amid fintech corrections" |

**Shift assessment:** Consistently confident-to-bullish throughout FY2025. Q4 was the most assertive quarter — management led with superlative language. No defensive or cautious signals detected.

## Analyst Concern Tracker

| Concern | First Raised | Status |
|---------|-------------|--------|
| Growth deceleration sustainability | Q2 FY25 (inferred) | **Active** — 5 consecutive quarters of YoY deceleration; FY26 guide implies continuation |
| AI commercial timeline | Q4 FY25 | **Active** — management confirmed work but gave no timeline or revenue impact |
| OpEx increase vs margin | Q4 FY25 | **Resolved** — CFO characterized as "opportunity capture, not cost creep"; incremental margins 58-61% |
| Beat magnitude compression | Q4 FY25 | **New** — Q4 beat 6.8% (narrowest in 7Q); 3 of last 4Q below 12%. Core thesis risk if pattern continues. |
| Contribution margin compression | Q4 FY23 | **Active** — 40.2% to 32.3% over 8Q (-790bp). Operating leverage currently offsetting but cannot continue indefinitely. |

## Source Log

| Date | Persona | What Changed |
|------|---------|-------------|
| 2026-04-02 | atlas | Created _ROLLING.md from Q4 FY25 analysis. Populated 4-quarter grid, promise tracker, language shift, analyst concerns. |
| 2026-04-03 | atlas | Earnings review Q4 FY25. Revised Q3 promise status (Met → Beat). Added beat magnitude compression and contribution margin compression to analyst concerns. Created Q4_FY25.md quarter file. |
| 2026-04-06 | wsm | Stock analysis. Reviewed full 16Q dataset + transcript. Confirmed structural growth deceleration thesis: revenue/txn gap narrowing (23.4pp→12.1pp), quarterly beat magnitude compressing. No changes to promise tracker or analyst concerns — agree with atlas assessments. |
FQCalRev (M)YoYGMOp MFCF M
Q4_FY25 Dec-2025 330.5 28.2% 25.4% 7.3% 10.8%
Q3_FY25 Sep-2025 310.7 34.2% 24.1% 6.4% 8.3%
Q2_FY25 Jun-2025 280.1 41.9% 25.5% 5.7% 8.0%
Q1_FY25 Mar-2025 275.2 48.8% 24.0% 5.7% 14.9%
Q4_FY24 Dec-2024 257.9 56.5% 25.6% 5.5% 7.3%
Q3_FY24 Sep-2024 231.6 52.0% 26.2% 5.2% -1.0%
Q2_FY24 Jun-2024 197.4 32.6% 29.8% 5.2% 4.4%
Q1_FY24 Mar-2024 184.9 24.7% 28.5% 4.5% 0.8%
Q4_FY23 Dec-2023 164.8 24.7% 30.0% 5.5% 9.7%
Q3_FY23 Sep-2023 152.4 18.9% 30.8% 3.5% 2.8%
Q2_FY23 Jun-2023 148.9 24.1% 30.8% 3.1% 12.0%
Q1_FY23 Mar-2023 148.3 27.1% 27.0% -0.7% 3.2%
Q4_FY22 Dec-2022 132.2 22.3% 31.1% 1.1% 5.4%
Q3_FY22 Sep-2022 128.2 26.1% 29.6% -0.7% -8.0%
Q2_FY22 Jun-2022 120.0 28.3% 29.8% -1.8% -3.5%
Q1_FY22 Mar-2022 116.7 26.6% 29.9% -1.2% 2.3%